Patent details

EP2175834 Title: GLP-1-FC FUSION PROTEIN FORMULATION

Basic Information

Publication number:
EP2175834
PCT Application Number:
PCT/US/2008/069473
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087724670
PCT Publication Number:
WO/2009/009562
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GLP-1-FC FUSION PROTEIN FORMULATION
French Title of Invention:
FORMULATION DE PROTÉINE DE FUSION GLP-1-FC
German Title of Invention:
GLP-1-FC FUSIONSPROTEIN-FORMULIERUNG
SPC Number:

Dates

Filing date:
09/07/2008
Grant date:
23/02/2011
EP Publication Date:
23/02/2011
PCT Publication Date:
15/01/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/04/2010
EP B1 Publication Date:
23/02/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/07/2011
Expiration date:
09/07/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/07/2008
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
23/02/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
NG Kingman
Address:
United States (US)

Priority

Priority Number:
948855 P
Priority Date:
10/07/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/08;
Filing date Document type Number of pages